Engineered immune cells help reduce toxic proteins in the brain
Researchers at WashU Medicine and Weizmann Institute of Science designed a CAR-T cell therapy that reduced amyloid beta plaques in the brains of mice, pointing to a promising new approach for Alzheimer’s disease.
From the experts
Find an expert
Perspectives
How ‘Harm Reduction’ Fails Families
No one is suggesting that a single positive drug test or instance of drug use should automatically trigger the removal of children from the home. But we must abandon the delusion that parents who are drug-addicted will enter treatment voluntarily before serious harm falls to them or their children, writes Sarah Font.
Professor analyzes verdict against Uber
Michael Green, a visiting professor and an expert in tort law at WashU Law, discusses the implications of the $8.5 million federal jury verdict against Uber in a case alleging sexual assault by a driver.
Why is US health care still the most expensive in the world after decades of cost-cutting initiatives?
Health care is extremely complicated and there are numerous barriers to reforms, as successive U.S. administrations have learned over the years. Whether the Trump administration finds some success will depend on how well the policies are able to surmount these and other obstacles, writes Patrick Aguilar.
Videos
Researcher for a day
WashU engineer Marcus Foston regularly hosts middle school students to learn about cutting-edge science. It’s part of WashU’s immersive “Researcher for a Day” program.
Bookshelf
A new ‘Paradiso’
Celebrated poet Mary Jo Bang completes the third book in a modern translation of The Divine Comedy, an effort that took two decades.